FXR agonists

Terns Pharmaceuticals touts safety data from an ex-Eli Lilly candidate in the hunt for NASH treatment
Endpoints
Tue, 06/15/21 - 11:35 pm
Terns Pharmceuticals
Eli Lilly
FXR agonists
NASH
Gilead's FXR agonist among NASH therapies highlighted ahead of AASLD
BioCentury
Tue, 10/2/18 - 11:01 pm
Gilead Sciences
NASH
GS-9674
FXR agonists